HUS1600039I1 - Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával - Google Patents

Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Info

Publication number: HUS1600039I1
Authority: HU; Hungary
Prior art keywords: oritavancin; treatments; single doses; doses
Prior art date: 2008-08-30

Application number

HUS1600039C

Other languages

English (en)

Original Assignee

The Medicines Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-30

Filing date

2016-10-06

Publication date

2016-11-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS1600039(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-10-06 Application filed by The Medicines Co filed Critical The Medicines Co

2016-11-28 Publication of HUS1600039I1 publication Critical patent/HUS1600039I1/hu

Links

VHFGEBVPHAGQPI-MYYQHNLBSA-N oritavancin Chemical compound O([C@@H]1C2=CC=C(C(=C2)Cl)OC=2C=C3C=C(C=2O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@@](C)(NCC=4C=CC(=CC=4)C=4C=CC(Cl)=CC=4)C2)OC2=CC=C(C=C2Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]2C(=O)N[C@@H]1C(N[C@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1 VHFGEBVPHAGQPI-MYYQHNLBSA-N 0.000 title 1
229960001607 oritavancin Drugs 0.000 title 1
108010006945 oritavancin Proteins 0.000 title 1
238000011282 treatment Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

HUS1600039C 2008-08-30 2016-10-06 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával HUS1600039I1 (hu)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US9331408P	2008-08-30	2008-08-30
US9349708P	2008-09-02	2008-09-02
EP09810708.9A EP2337575B1 (en)	2008-08-30	2009-08-29	Methods of treatment using single doses of oritavancin

Publications (1)

Publication Number	Publication Date
HUS1600039I1 true HUS1600039I1 (hu)	2016-11-28

Family

ID=41722337

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
HUE09810708A HUE027373T2 (hu)	2008-08-30	2009-08-29	Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUE15195726A HUE068423T2 (hu)	2008-08-30	2009-08-29	Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére
HUS1600039C HUS1600039I1 (hu)	2008-08-30	2016-10-06	Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
HUE09810708A HUE027373T2 (hu)	2008-08-30	2009-08-29	Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUE15195726A HUE068423T2 (hu)	2008-08-30	2009-08-29	Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére

Country Status (18)

Country	Link
US (2)	US8420592B2 (hu)
EP (3)	EP4464375A3 (hu)
JP (1)	JP5782615B2 (hu)
CN (2)	CN102215858A (hu)
AU (1)	AU2009285564B2 (hu)
CA (1)	CA2736860C (hu)
DK (2)	DK3006038T3 (hu)
EA (1)	EA020490B1 (hu)
ES (2)	ES2570401T3 (hu)
FI (1)	FI3006038T3 (hu)
HU (3)	HUE027373T2 (hu)
MX (1)	MX2011002249A (hu)
NL (1)	NL300834I2 (hu)
NO (1)	NO2016019I2 (hu)
NZ (1)	NZ591525A (hu)
PL (2)	PL2337575T3 (hu)
PT (1)	PT3006038T (hu)
WO (1)	WO2010025438A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102215858A (zh) *	2008-08-30	2011-10-12	塔尔甘塔治疗公司	使用单剂量奥利万星的治疗方法
JP2012525391A (ja) *	2009-04-28	2012-10-22	ターガンタセラピューティクスコーポレイション	オリタバンシンを用いた細菌感染の治療方法
US20150246024A1 (en) *	2012-08-20	2015-09-03	The University Of Chicago	Methods and compositions for inhibiting gram positive bacteria
WO2014176068A2 (en) *	2013-04-22	2014-10-30	The Medicines Company	Treatment and prevention of bacterial skin infections using oritavancin
PT3038616T (pt) *	2013-08-26	2023-04-17	Melinta Therapeutics Inc	Métodos para tratamento de bacteriemia e osteomielite utilizando oritavancina
EP3038615A4 (en) *	2013-08-28	2017-04-12	The Medicines Company	Methods for treating bacterial infections using oritavancin and polymyxins
US20170119793A1 (en) *	2014-06-12	2017-05-04	Cem-102 Pharmaceuticals, Inc.	Compositions and methods for treating bone and joint infections
EP4509178A2 (en) *	2014-07-17	2025-02-19	Melinta Therapeutics, LLC	High purity oritavancin and method of producing same
US20170239323A1 (en) *	2016-02-18	2017-08-24	The Medicines Company	Oritavancin formulations
US20200171124A1 (en) *	2016-04-15	2020-06-04	Lupin Limited	Topical compositions for ophthalmic and otic use
CN108409837B (zh) *	2018-03-06	2021-09-24	上海来益生物药物研究开发中心有限责任公司	一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840684A (en)	1994-01-28	1998-11-24	Eli Lilly And Company	Glycopeptide antibiotic derivatives
US5994297A (en)	1997-08-22	1999-11-30	Eli Lilly And Company	Therapy for Staphylococcus aureus
NZ514467A (en)	1999-05-03	2005-01-28	Lilly Co Eli	Long-term prevention of streptococcus pneumonia infection with a monthly dose of NDISAcc-(4-(4-chlorophenyl) benzyl) A82846B or teicoplanin
EP1278549B1 (en)	2000-05-02	2008-12-10	Theravance, Inc.	Composition containing a cyclodextrin and a glycopeptide antibiotic
US20030176327A1 (en) *	2001-10-25	2003-09-18	Cassell Gail Houston	Antibiotics for treating biohazardous bacterial agents
WO2003102134A2 (en) *	2002-05-28	2003-12-11	Becton, Dickinson And Company	Pancreatic acinar cells into insulin producing cells
US20040147441A1 (en)	2002-08-23	2004-07-29	Leach Timothy S.	Methods and reagents for preventing bacteremias
US20040127403A1 (en) *	2002-09-06	2004-07-01	Francesco Parenti	Methods for treating and preventing Gram-positive bacteremias
US20070249577A1 (en) *	2005-05-10	2007-10-25	Hopkins Scott J	Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
WO2008097364A2 (en)	2006-09-25	2008-08-14	Targanta Therapeutics Corp.	Use of oritavancin for prevention and treatment of anthrax
CN102215858A (zh) *	2008-08-30	2011-10-12	塔尔甘塔治疗公司	使用单剂量奥利万星的治疗方法
JP2012525391A (ja) *	2009-04-28	2012-10-22	ターガンタセラピューティクスコーポレイション	オリタバンシンを用いた細菌感染の治療方法
EP3038615A4 (en) *	2013-08-28	2017-04-12	The Medicines Company	Methods for treating bacterial infections using oritavancin and polymyxins

2009
- 2009-08-29 CN CN2009801439475A patent/CN102215858A/zh active Pending
- 2009-08-29 PT PT151957263T patent/PT3006038T/pt unknown
- 2009-08-29 CN CN201610900690.5A patent/CN106620649A/zh active Pending
- 2009-08-29 EP EP24186111.1A patent/EP4464375A3/en active Pending
- 2009-08-29 US US13/060,811 patent/US8420592B2/en active Active
- 2009-08-29 HU HUE09810708A patent/HUE027373T2/hu unknown
- 2009-08-29 ES ES09810708T patent/ES2570401T3/es active Active
- 2009-08-29 WO PCT/US2009/055466 patent/WO2010025438A2/en active Application Filing
- 2009-08-29 JP JP2011525264A patent/JP5782615B2/ja active Active
- 2009-08-29 EA EA201100413A patent/EA020490B1/ru unknown
- 2009-08-29 AU AU2009285564A patent/AU2009285564B2/en active Active
- 2009-08-29 MX MX2011002249A patent/MX2011002249A/es active IP Right Grant
- 2009-08-29 DK DK15195726.3T patent/DK3006038T3/da active
- 2009-08-29 ES ES15195726T patent/ES2994966T3/es active Active
- 2009-08-29 NZ NZ591525A patent/NZ591525A/en unknown
- 2009-08-29 HU HUE15195726A patent/HUE068423T2/hu unknown
- 2009-08-29 PL PL09810708.9T patent/PL2337575T3/pl unknown
- 2009-08-29 CA CA2736860A patent/CA2736860C/en active Active
- 2009-08-29 PL PL15195726.3T patent/PL3006038T3/pl unknown
- 2009-08-29 EP EP09810708.9A patent/EP2337575B1/en not_active Revoked
- 2009-08-29 FI FIEP15195726.3T patent/FI3006038T3/fi active
- 2009-08-29 DK DK09810708.9T patent/DK2337575T3/en active
- 2009-08-29 EP EP15195726.3A patent/EP3006038B1/en active Active
2013
- 2013-02-11 US US13/763,799 patent/US20130172237A1/en active Pending
2016
- 2016-10-06 HU HUS1600039C patent/HUS1600039I1/hu unknown
- 2016-10-11 NO NO2016019C patent/NO2016019I2/no unknown
- 2016-10-11 NL NL300834C patent/NL300834I2/nl unknown

Also Published As

Publication number	Publication date
US20130172237A1 (en)	2013-07-04
CN106620649A (zh)	2017-05-10
JP2012501349A (ja)	2012-01-19
NO2016019I1 (no)	2016-10-11
NO2016019I2 (no)	2019-01-25
EP4464375A3 (en)	2025-02-26
AU2009285564A1 (en)	2010-03-04
EP2337575A4 (en)	2012-10-17
AU2009285564B2 (en)	2014-05-22
WO2010025438A2 (en)	2010-03-04
HUE068423T2 (hu)	2024-12-28
PL3006038T3 (pl)	2024-11-12
DK3006038T3 (da)	2024-08-26
NL300834I2 (hu)	2016-11-16
EA020490B1 (ru)	2014-11-28
US8420592B2 (en)	2013-04-16
EP4464375A2 (en)	2024-11-20
PL2337575T3 (pl)	2016-09-30
EP2337575B1 (en)	2016-04-13
EA201100413A1 (ru)	2012-01-30
JP5782615B2 (ja)	2015-09-24
CN102215858A (zh)	2011-10-12
DK2337575T3 (en)	2016-05-23
ES2570401T3 (es)	2016-05-18
HUE027373T2 (hu)	2016-09-28
EP3006038A1 (en)	2016-04-13
CA2736860A1 (en)	2010-03-04
NZ591525A (en)	2014-03-28
PT3006038T (pt)	2024-08-23
US20110201546A1 (en)	2011-08-18
EP2337575A1 (en)	2011-06-29
FI3006038T3 (fi)	2024-08-12
EP3006038B1 (en)	2024-07-03
CA2736860C (en)	2020-04-28
ES2994966T3 (en)	2025-02-04
WO2010025438A9 (en)	2010-05-14
MX2011002249A (es)	2011-06-24

Publication	Publication Date	Title
HUS1600039I1 (hu)	2016-11-28	Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
BRPI0914789A2 (pt)	2015-10-20	efeitos sinérgicos
BRPI0906366A2 (pt)	2015-07-07	Inalador
BRPI0916931A2 (pt)	2015-11-24	agentes terapêuticos
BRPI0914817A2 (pt)	2015-10-27	inalador
DK2326651T3 (da)	2014-01-20	Buprenorphinanaloger
ATE526024T1 (de)	2011-10-15	Fluvoxamin vermeidende pirfenidontheraphy
DK2330887T3 (da)	2013-05-21	Behandlingsindretning
HUE036071T2 (hu)	2018-06-28	Macitentánt tartalmazó terápiás készítmények
DE112010004110T8 (de)	2012-12-06	Neue parasitentherapie
BRPI0910534A2 (pt)	2015-09-29	terapia antiviral
BRPI0917684A2 (pt)	2015-12-01	método terapêutico homeopático
LT3150178T (lt)	2021-08-10	Stimuliavimo aparatas
IT1392670B1 (it)	2012-03-16	Iniettore
DK2379722T3 (da)	2017-01-02	Ekspressionsvektor
BRPI0822264A2 (pt)	2014-09-30	Dapsona para tratar rosácea
BRPI0906369A2 (pt)	2015-07-07	Inalador
DE112009000350A5 (de)	2011-03-17	Einspritzvorrichtung
BRPI1013903A2 (pt)	2016-07-19	tratamentos terapêuticos utilizando centaquina
EP2309854A4 (en)	2012-06-06	ACCELERATED THERAPY:
SMT201500123B (it)	2015-09-07	Dosaggio unitario di apadenoson
BRPI0909764A2 (pt)	2015-10-06	compostos terapêuticos
EP2266520A4 (en)	2014-03-19	Massage machine
BRPI0906879A2 (pt)	2015-07-07	Compostos terapêuticos
IT1391542B1 (it)	2012-01-11	Cassaforte